Abstract
Chronic alcohol abuse has a detrimental effect on the brain and liver. There is no effective treatment for these patients, and the mechanism underlying alcohol addiction and consequent alcohol-induced damage of the liver/brain axis remains unresolved. We compared experimental models of alcoholic liver disease (ALD) and alcohol dependence in mice and demonstrated that genetic ablation of IL-17 receptor A (IL-17ra –/– ) or pharmacological blockade of IL-17 signaling effectively suppressed the increased voluntary alcohol drinking in alcohol-dependent mice and blocked alcohol-induced hepatocellular and neurological damage. The level of circulating IL-17A positively correlated with the alcohol use in excessive drinkers and was further increased in patients with ALD as compared with healthy individuals. Our data suggest that IL-17A is a common mediator of excessive alcohol consumption and alcohol-induced liver/brain injury, and targeting IL-17A may provide a novel strategy for treatment of alcohol-induced pathology.
Funding Information
  • Norges Idrettshøgskole (NIDDK)
  • American Liver Foundation (Herman Lopata Memorial Hepatitis Postdoctoral ALF Fellowship)
  • Norges Idrettshøgskole (NIHNS)
  • Norges Idrettshøgskole (R01 DK101737-01A1,U01 AA022614-01A1,R01 DK099205-01A1,P50AA011999,AI043477,AI043477 NS093055,NS054734,R01 CA 100660,R01 AA020864,R21AA024935,R01 DK107682,R01 AA025208,1I01CX000361,R21 AA024198,P60 AA006420,R01 AA021491)

This publication has 61 references indexed in Scilit: